308 related articles for article (PubMed ID: 29433510)
1. Review and critical appraisal of studies mapping from quality of life or clinical measures to EQ-5D: an online database and application of the MAPS statement.
Dakin H; Abel L; Burns R; Yang Y
Health Qual Life Outcomes; 2018 Feb; 16(1):31. PubMed ID: 29433510
[TBL] [Abstract][Full Text] [Related]
2. 'Mapping' Health State Utility Values from Non-preference-Based Measures: A Systematic Literature Review in Rare Diseases.
Meregaglia M; Whittal A; Nicod E; Drummond M
Pharmacoeconomics; 2020 Jun; 38(6):557-574. PubMed ID: 32152892
[TBL] [Abstract][Full Text] [Related]
3. Converting Parkinson-Specific Scores into Health State Utilities to Assess Cost-Utility Analysis.
Chen G; Garcia-Gordillo MA; Collado-Mateo D; Del Pozo-Cruz B; Adsuar JC; Cordero-Ferrera JM; Abellán-Perpiñán JM; Sánchez-Martínez FI
Patient; 2018 Dec; 11(6):665-675. PubMed ID: 29876865
[TBL] [Abstract][Full Text] [Related]
4. Mapping the SRS-22r questionnaire onto the EQ-5D-5L utility score in patients with adolescent idiopathic scoliosis.
Wong CKH; Cheung PWH; Samartzis D; Luk KD; Cheung KMC; Lam CLK; Cheung JPY
PLoS One; 2017; 12(4):e0175847. PubMed ID: 28414745
[TBL] [Abstract][Full Text] [Related]
5. Preferred reporting items for studies mapping onto preference-based outcome measures: The MAPS statement.
Petrou S; Rivero-Arias O; Dakin H; Longworth L; Oppe M; Froud R; Gray A
Health Qual Life Outcomes; 2015 Aug; 13():106. PubMed ID: 26232268
[TBL] [Abstract][Full Text] [Related]
6. Comparing EQ-5D valuation studies: a systematic review and methodological reporting checklist.
Xie F; Gaebel K; Perampaladas K; Doble B; Pullenayegum E
Med Decis Making; 2014 Jan; 34(1):8-20. PubMed ID: 23525701
[TBL] [Abstract][Full Text] [Related]
7. Mapping the FACT-B Instrument to EQ-5D-3L in Patients with Breast Cancer Using Adjusted Limited Dependent Variable Mixture Models versus Response Mapping.
Gray LA; Wailoo AJ; Hernandez Alava M
Value Health; 2018 Dec; 21(12):1399-1405. PubMed ID: 30502783
[TBL] [Abstract][Full Text] [Related]
8. Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement.
Petrou S; Rivero-Arias O; Dakin H; Longworth L; Oppe M; Froud R; Gray A
Pharmacoeconomics; 2015 Oct; 33(10):985-91. PubMed ID: 26232201
[TBL] [Abstract][Full Text] [Related]
9. Review of studies mapping from quality of life or clinical measures to EQ-5D: an online database.
Dakin H
Health Qual Life Outcomes; 2013 Sep; 11():151. PubMed ID: 24010873
[TBL] [Abstract][Full Text] [Related]
10. A systematic literature review of health state utility values in head and neck cancer.
Meregaglia M; Cairns J
Health Qual Life Outcomes; 2017 Sep; 15(1):174. PubMed ID: 28865475
[TBL] [Abstract][Full Text] [Related]
11. Assessing outcomes for cost-utility analysis in mental health interventions: mapping mental health specific outcome measure GHQ-12 onto EQ-5D-3L.
Lindkvist M; Feldman I
Health Qual Life Outcomes; 2016 Sep; 14(1):134. PubMed ID: 27644119
[TBL] [Abstract][Full Text] [Related]
12. Mapping the EORTC QLQ-C30 onto the EQ-5D-3L: assessing the external validity of existing mapping algorithms.
Doble B; Lorgelly P
Qual Life Res; 2016 Apr; 25(4):891-911. PubMed ID: 26391884
[TBL] [Abstract][Full Text] [Related]
13. An Updated Systematic Review of Studies Mapping (or Cross-Walking) Measures of Health-Related Quality of Life to Generic Preference-Based Measures to Generate Utility Values.
Mukuria C; Rowen D; Harnan S; Rawdin A; Wong R; Ara R; Brazier J
Appl Health Econ Health Policy; 2019 Jun; 17(3):295-313. PubMed ID: 30945127
[TBL] [Abstract][Full Text] [Related]
14. The MAPS Reporting Statement for Studies Mapping onto Generic Preference-Based Outcome Measures: Explanation and Elaboration.
Petrou S; Rivero-Arias O; Dakin H; Longworth L; Oppe M; Froud R; Gray A
Pharmacoeconomics; 2015 Oct; 33(10):993-1011. PubMed ID: 26232200
[TBL] [Abstract][Full Text] [Related]
15. Generating EQ-5D-3L Utility Scores from the Dermatology Life Quality Index: A Mapping Study in Patients with Psoriasis.
Davison NJ; Thompson AJ; Turner AJ; Longworth L; McElhone K; Griffiths CEM; Payne K;
Value Health; 2018 Aug; 21(8):1010-1018. PubMed ID: 30098665
[TBL] [Abstract][Full Text] [Related]
16. Mapping the COPD Assessment Test onto EQ-5D.
Hoyle CK; Tabberer M; Brooks J
Value Health; 2016 Jun; 19(4):469-77. PubMed ID: 27325339
[TBL] [Abstract][Full Text] [Related]
17. Mapping PROMIS Global Health Items to EuroQol (EQ-5D) Utility Scores Using Linear and Equipercentile Equating.
Thompson NR; Lapin BR; Katzan IL
Pharmacoeconomics; 2017 Nov; 35(11):1167-1176. PubMed ID: 28710740
[TBL] [Abstract][Full Text] [Related]
18. Preferred reporting items for studies mapping onto preference-based outcome measures: the MAPS statement.
Petrou S; Rivero-Arias O; Dakin H; Longworth L; Oppe M; Froud R; Gray A
Qual Life Res; 2016 Feb; 25(2):275-281. PubMed ID: 26231589
[TBL] [Abstract][Full Text] [Related]
19. Reducing waste in collection of quality-of-life data through better reporting: a case study.
McCreanor V; Lum E; Graves N; Luo N; Parsonage W; Barnett A
Qual Life Res; 2022 Oct; 31(10):2931-2938. PubMed ID: 35072906
[TBL] [Abstract][Full Text] [Related]
20. Health-Related Quality of Life in Patients With Different Diseases Measured With the EQ-5D-5L: A Systematic Review.
Zhou T; Guan H; Wang L; Zhang Y; Rui M; Ma A
Front Public Health; 2021; 9():675523. PubMed ID: 34268287
[No Abstract] [Full Text] [Related]
[Next] [New Search]
